Oruka Therapeutics, Inc. (ORKA) — SC 13D/A Filings
All SC 13D/A filings from Oruka Therapeutics, Inc.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Fairmount Funds Adjusts Oruka Therapeutics Stake
— Nov 21, 2024 Risk: medium
Fairmount Funds Management LLC, along with its affiliates Fairmount Healthcare Co-Invest III L.P. and Fairmount Healthcare Fund II L.P., has amended their Sched -
Adage Capital Management Amends Oruka Therapeutics Filing
— Oct 22, 2024 Risk: medium
Adage Capital Management, L.P. has amended its Schedule 13D filing regarding Oruka Therapeutics, Inc. on October 22, 2024. The filing indicates a change in bene
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX